Ki-67 Antigen; A Valuable Prognostic Biomarker for Chronic Lymphocytic Leukemia

Background: Chronic lymphocytic leukemia (CLL) is one of the most common blood malignancies. The chief cells involved in this malignancy are in the G0 phase of cell division and have no proliferative activity; however, what determines the severity and prognosis of this disease is cell proliferation....

Full description

Bibliographic Details
Published in:	مجله دانشکده پزشکی اصفهان
Main Authors:	Valiollah Mehrzad, Samaneh Madadi
Format:	Article
Language:	Persian
Published:	Isfahan University of Medical Sciences 2022-01-01
Subjects:	biomarker ki-67 antigen chronic lymphocytic leukemia prognosis
Online Access:	https://jims.mui.ac.ir/article_26285_21bc85415bebef16bcd66227a9a79fbd.pdf

Similar Items

Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis
by: Ayla Bahramian, et al.
Published: (2024-12-01)

Evaluation of Bcl 2 and Ki 67 expression in Chronic Lymphocytic Leukemia .
by: Subh S. AL- Mudallal, et al.
Published: (2013-01-01)

The impact of stratified management of Ki-67 on the prognosis of small-cell lung cancer
by: Xiaofang Zhang, et al.
Published: (2025-07-01)

Association between Ki-67 expression and clinicopathological features in prognosis of breast cancer: A retrospective cohort study
by: Hosein Kamranzadeh, et al.
Published: (2019-01-01)

Ki-67 Biomarker Expression and Its Relationship with Metastasis Time and Location in Breast Cancer Patients
by: Abdolreza Fazel, et al.
Published: (2025-10-01)

Predictive Value of Combined Preoperative Carcinoembryonic Antigen Level and Ki-67 Index in Patients With Gastric Neuroendocrine Carcinoma After Radical Surgery
by: Jianwei Xie, et al.
Published: (2021-03-01)

The cell proliferation antigen Ki-67 organises heterochromatin
by: Michal Sobecki, et al.
Published: (2016-03-01)

Immunohistochemical Expression of Ki-67 and p53 and Their Prognostic Role in Ameloblastoma: A Longitudinal Study
by: James J. Yahaya, et al.
Published: (2024-02-01)

Peripheral Neutrophil to Lymphocyte Ratio (NLR), a cogent clinical adjunct for Ki-67 in breast cancer
by: Radhika Arora, et al.
Published: (2023-12-01)

Variability in the Epithelial Expression of Ki67 and Polarization Characteristics of Collagen in Odontogenic Cysts and Tumours
by: Shakthi Dorai Bhadravathi, et al.
Published: (2023-09-01)

Application value of Ki67 and serum CA125 in the deep myometrial invasion of endometrial adenocarcinoma
by: Lin Qin
Published: (2023-03-01)

Computer-assisted quantitative analysis of Ki-67 antigen in dysplasia: Associated lesions or masses in ulcerative colitis
by: Živković Vesna, et al.
Published: (2007-01-01)

Cyclooxygenase-2 and Ki67 Expression in Oral Leukoplakia: a Clinicopathological Study
by: Alper Sinanoglu, et al.
Published: (2015-06-01)

Prediction of the Ki-67 marker index in hepatocellular carcinoma based on Dynamic Contrast-Enhanced Ultrasonography with Sonazoid
by: Zhe Huang, et al.
Published: (2022-12-01)

Identification and prognostic significance of Ki-67-related genes in triple negative breast cancer
by: Wenhan Li, et al.
Published: (2025-09-01)

Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01)

Prognostic Value of Ki67 and Other Clinical and Histopathological Factors in Canine Apocrine Gland Anal Sac Adenocarcinoma
by: Emanuela Maria Morello, et al.
Published: (2021-06-01)

Clinicopathological and prognostic value of Ki-67 expression in oral malignant melanoma: A systematic review and meta-analysis
by: Mohammad Hossein Moltajaei, et al.
Published: (2022-11-01)

Expression of nuclear Ki-67 antigen in prostatic high grade intraepithelial neoplasia and prostatic carcinoma
by: Janković-Veličković Ljubinka, et al.
Published: (2007-01-01)

Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma
by: Yuexiang Liang, et al.
Published: (2024-05-01)

Deep learning–based radiomic nomograms for predicting Ki67 expression in prostate cancer
by: Shuitang Deng, et al.
Published: (2023-07-01)

Study of morphology with assessment of expression of proliferation marker Ki67 antigen and P53 protein in lesions of gall bladder
by: Ojasvi Ramesh, et al.
Published: (2024-04-01)

Role of topoisomerase II α and Ki -67 biomarkers in pituitary tumors
by: Chhanda Das, et al.
Published: (2023-12-01)

Evaluation of salivary Ki-67 in health and periodontitis
by: Mohamed Abdalla Ali Ahmed, et al.
Published: (2025-03-01)

Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis
by: Christina Marouda, et al.
Published: (2024-01-01)

Effect of expression of immunohistochemical marker Ki-67 on the life expectancy of patients with gastric cancer 0-III stages
by: O. M. Levyk, et al.
Published: (2015-08-01)

Evaluation of the proliferation marker Ki67 as a prognostic factor in patients with breast carcinoma
by: Fatima S. Al-Sarraf, et al.
Published: (2015-07-01)

The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients
by: Pascale Mariarosa, et al.
Published: (2016-09-01)

Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR
by: Tao Li, et al.
Published: (2023-03-01)

Relationship Between SUVmax and Ki-67 Expression in Breast Cancer
by: Meriç Emre Bostancı, et al.
Published: (2020-09-01)

Investigation of Ki-67 and Clinical Outcome in Feline Nasal Adenocarcinoma Treated Using Hypofractionated Radiotherapy
by: Premkamon Aonta, et al.
Published: (2024-12-01)

Is Ki-67, keratin 16, involucrin, and filaggrin immunostaining sufficient to diagnose inflammatory linear verrucous epidermal nevus? A report of eight cases and a comparison with psoriasis vulgaris
by: Jing Peng, et al.
Published: (2017-10-01)

Prognostic predictive value of Ki-67 in stage I–II triple-negative breast cancer
by: Fengyan Li, et al.
Published: (2023-11-01)

Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma
by: Xihua Yang, et al.
Published: (2023-01-01)

The Expression of Testin, Ki-67 and p16 in Cervical Cancer Diagnostics
by: Aneta Popiel-Kopaczyk, et al.
Published: (2023-01-01)

Correlation of Ki67 expression with estrogen receptor (ER) and progesterone receptor (PR) status in breast cancer
by: Dedy Hermansyah, et al.
Published: (2025-08-01)

Ki-67—Playing a key role in breast cancer but difficult to apply precisely in the real world
by: Changsong Wang, et al.
Published: (2025-05-01)

Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung
by: Rashi GARG, et al.
Published: (2019-01-01)

Ki67 and p53 in gastrointestinal stromal tumors - GIST Ki67 and p53 em tumores estromais gastrointestinais - GIST
by: Lúcio Roberto de Oliveira das Neves, et al.
Published: (2009-06-01)

Prognostic Importance of Ki-67 in Breast Cancer and Its Relationship with Other Prognostic Factors
by: Gül Kanyılmaz, et al.
Published: (2019-10-01)